Leanna Gould
Family · Norton Shores, MINPI 1639739451
Payments from drug & device makers
Across 421 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$540
- Novo Nordisk$517
- Otsuka America Pharmaceutical, Inc.$363
- GSK$313
- plus $3K from 39 others
What the payments were for
- Food & beverage$7,231100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$125
How this compares
$7,231 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 58 | $95,529 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 64 | $49,430 |
| EliquisApixaban | 40 | $47,902 |
| MounjaroTirzepatide | 25 | $47,878 |
| OzempicSemaglutide | 28 | $40,637 |
| JanuviaSitagliptin Phosphate | 26 | $40,142 |
| FarxigaDapagliflozin Propanediol | 20 | $18,666 |
| JardianceEmpagliflozin | 11 | $18,433 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $13,527 |
| Risperdal ConstaRisperidone Microspheres | 19 | $10,913 |
| SymbicortBudesonide/Formoterol Fumarate | 40 | $9,438 |
| Incruse ElliptaUmeclidinium Bromide | 24 | $8,100 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $7,072 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 197 | $6,844 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 50 | $3,298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $168 | $143,40783 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $313 | $71,057107 claims |
| PfizerEliquis | $236 | $47,90240 claims |
| Novo NordiskOzempic | $517 | $40,63728 claims |
| MerckJanuvia | $65 | $40,14226 claims |
| AstraZenecaFarxiga, Symbicort | $48 | $28,10460 claims |
| Boehringer IngelheimJardiance | $82 | $18,43311 claims |
| AbbVieSynthroid | $1,102 | $1,98421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Norton Shores
- April LuchtNorton Shores$10K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.